GenMark Diagnostics Quick Ratio 2010-2019 | GNMK

Historical quick ratio values for GenMark Diagnostics (GNMK) over the last 10 years.
GenMark Diagnostics Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2019-09-30 $0.05B $0.02B 2.11
2019-06-30 $0.05B $0.02B 2.83
2019-03-31 $0.06B $0.02B 3.40
2018-12-31 $0.06B $0.02B 2.87
2018-09-30 $0.05B $0.02B 3.10
2018-06-30 $0.06B $0.04B 1.80
2018-03-31 $0.08B $0.03B 2.45
2017-12-31 $0.09B $0.03B 3.06
2017-09-30 $0.10B $0.04B 2.77
2017-06-30 $0.12B $0.03B 3.39
2017-03-31 $0.03B $0.02B 1.57
2016-12-31 $0.05B $0.03B 1.96
2016-09-30 $0.06B $0.02B 3.05
2016-06-30 $0.04B $0.02B 2.79
2016-03-31 $0.04B $0.01B 3.82
2015-12-31 $0.05B $0.01B 5.00
2015-09-30 $0.06B $0.01B 5.18
2015-06-30 $0.07B $0.01B 7.23
2015-03-31 $0.08B $0.01B 7.93
2014-12-31 $0.08B $0.01B 6.18
2014-09-30 $0.08B $0.01B 7.20
2014-06-30 $0.09B $0.01B 7.92
2014-03-31 $0.10B $0.01B 9.98
2013-12-31 $0.11B $0.01B 10.65
2013-09-30 $0.12B $0.01B 13.78
2013-06-30 $0.04B $0.01B 5.42
2013-03-31 $0.05B $0.01B 6.23
2012-12-31 $0.06B $0.01B 6.11
2012-09-30 $0.06B $0.01B 7.56
2012-06-30 $0.07B $0.01B 9.76
2012-03-31 $0.03B $0.01B 4.64
2011-12-31 $0.03B $0.01B 4.97
2011-09-30 $0.04B $0.01B 5.79
2011-06-30 $0.05B $0.01B 6.72
2011-03-31 $0.02B $0.00B 4.11
2010-12-31 $0.02B $0.00B 6.54
2010-09-30 $0.03B $0.00B 6.67
2010-06-30 $0.03B $0.00B 8.52
2010-03-31 $0.00B 0.00
2009-12-31 $0.00B 0.00
2009-09-30 $0.00B 0.00
2009-06-30 $0.00B 0.00
2009-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.211B $0.071B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $123.970B 25.05
Intuitive Surgical (ISRG) United States $64.897B 48.44
Edwards Lifesciences (EW) United States $46.337B 39.78
ALCON INC (ALC) $30.849B 0.00
DexCom (DXCM) United States $25.486B 152.05
Olympus (OCPNY) Japan $24.747B 185.85
Fresenius Medical Care AG KGaA (FMS) Germany $23.524B 15.35
IDEXX Laboratories (IDXX) United States $22.139B 53.17
Teleflex (TFX) United States $16.009B 30.97
SONOVA HOLDING (SONVY) Switzerland $15.869B 0.00
STERIS (STE) Ireland $14.031B 29.92
Sysmex ADR (SSMXY) Japan $13.608B 36.63
Hologic (HOLX) United States $12.781B 19.65
Varian Medical Systems (VAR) United States $11.802B 27.46
Masimo (MASI) United States $8.929B 51.99
SARTORIUS AG (SARTF) Germany $7.663B 68.08
ABIOMED (ABMD) United States $6.944B 36.60
Penumbra (PEN) United States $5.994B 177.00
Globus Medical (GMED) United States $4.906B 29.20
Integra LifeSciences Holdings (IART) United States $4.589B 19.83
Tandem Diabetes Care (TNDM) United States $4.571B 0.00
Nevro (NVRO) United States $4.423B 0.00
Elekta AB (EKTAY) Sweden $4.229B 32.56
Wright Medical Group (WMGI) Netherlands $3.901B 233.08
Integer Holdings (ITGR) United States $3.105B 20.22
LivaNova (LIVN) United Kingdom $3.035B 22.16
Cantel Medical (CMD) United States $2.811B 27.50
Nihon Kohden (NHNKY) Japan $2.742B 27.59
Glaukos (GKOS) United States $2.230B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.568B 30.69
Silk Road Medical (SILK) United States $1.396B 0.00
ShockWave Medical (SWAV) United States $1.160B 0.00
Veracyte (VCYT) United States $1.157B 0.00
Mesa Laboratories (MLAB) United States $1.123B 58.78
Inogen (INGN) United States $1.055B 44.75
Luminex (LMNX) United States $1.047B 0.00
Tactile Systems Technology (TCMD) United States $1.030B 96.64
CryoLife (CRY) United States $1.016B 83.87
Natus Medical (NTUS) United States $0.961B 22.56
OPKO Health (OPK) United States $0.919B 0.00
OrthoPediatrics (KIDS) United States $0.816B 0.00
Accelerate Diagnostics (AXDX) United States $0.783B 0.00
Intersect ENT (XENT) United States $0.726B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.695B 24.82
Pacific Biosciences Of California (PACB) United States $0.517B 0.00
AxoGen (AXGN) United States $0.516B 0.00
Quotient (QTNT) Switzerland $0.508B 0.00
Si-Bone (SIBN) United States $0.476B 0.00
AngioDynamics (ANGO) United States $0.443B 20.31
Alphatec Holdings (ATEC) United States $0.374B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.361B 10.91
Semler Scientific (SMLR) United States $0.341B 47.50
ViewRay (VRAY) United States $0.304B 0.00
RTI Surgical (RTIX) United States $0.299B 81.00
IRadimed (IRMD) United States $0.283B 33.31
SeaSpine Holdings (SPNE) United States $0.281B 0.00
Accuray (ARAY) United States $0.278B 0.00
CRH Medical (CRHM) Canada $0.259B 72.40
Stereotaxis (STXS) United States $0.254B 0.00
Restoration Robotics (VERO) Canada $0.245B 0.00
Fluidigm (FLDM) United States $0.233B 0.00
Sientra (SIEN) United States $0.232B 0.00
Spectral Diagnostics (EDTXF) Canada $0.120B 0.00
EDAP TMS S.A (EDAP) France $0.116B 30.77
Electromed (ELMD) United States $0.099B 27.12
Vermillion (VRML) United States $0.087B 0.00
MRI Interventions (CLPT) United States $0.079B 0.00
Second Sight Medical Products (EYES) United States $0.077B 0.00
Sensus Healthcare (SRTS) United States $0.067B 0.00
Apollo Endosurgery (APEN) United States $0.057B 0.00
ConforMIS (CFMS) United States $0.056B 0.00
Neuronetics (STIM) United States $0.056B 0.00
Bioanalytical Systems (BASI) United States $0.052B 0.00
Ekso Bionics Holdings (EKSO) United States $0.032B 0.00
TransEnterix (TRXC) United States $0.032B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.032B 0.00
T2 Biosystems (TTOO) United States $0.029B 0.00
Helius Medical Technologies (HSDT) United States $0.027B 0.00
Neovasc (NVCN) Canada $0.027B 0.00
Ra Medical Systems (RMED) United States $0.020B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.018B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
Xtant Medical Holdings (XTNT) United States $0.015B 0.00
Allied Healthcare Products (AHPI) United States $0.015B 0.00
American Shared Hospital Services (AMS) United States $0.014B 19.73
OBALON THERPTCS (OBLN) United States $0.014B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
ENDRA Life Sciences (NDRA) United States $0.010B 0.00
ReWalk Robotics (RWLK) Israel $0.010B 0.00
Avinger (AVGR) United States $0.010B 0.00
Dynatronics (DYNT) United States $0.010B 0.00
Lianluo Smart (LLIT) China $0.008B 0.00
Micron Solutions (MICR) United States $0.008B 0.00
InspireMD (NSPR) Israel $0.004B 0.00
Viveve Medical (VIVE) United States $0.002B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00